BidaskClub downgraded shares of NantHealth (NASDAQ:NH) from a buy rating to a hold rating in a research report released on Friday morning.
Other equities research analysts also recently issued reports about the stock. Jefferies Financial Group set a $5.00 price target on shares of NantHealth and gave the company a buy rating in a research report on Wednesday, March 21st. Cowen reiterated a buy rating and issued a $4.50 price target on shares of NantHealth in a research report on Tuesday, March 20th. Finally, ValuEngine upgraded shares of NantHealth from a sell rating to a hold rating in a research report on Wednesday, May 2nd. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company has an average rating of Buy and an average price target of $4.69.
NantHealth opened at $3.43 on Friday, according to Marketbeat.com. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.90 and a quick ratio of 1.88. NantHealth has a 1-year low of $2.60 and a 1-year high of $5.26. The company has a market capitalization of $358.35 million, a PE ratio of -3.03 and a beta of 0.23.
NantHealth (NASDAQ:NH) last released its quarterly earnings results on Wednesday, May 9th. The company reported ($0.12) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.12). NantHealth had a negative net margin of 168.84% and a negative return on equity of 63.06%. The company had revenue of $22.26 million during the quarter, compared to the consensus estimate of $23.30 million. sell-side analysts anticipate that NantHealth will post -0.6 earnings per share for the current year.
Institutional investors and hedge funds have recently made changes to their positions in the business. Citadel Advisors LLC acquired a new position in shares of NantHealth during the fourth quarter worth $103,000. Deutsche Bank AG increased its holdings in shares of NantHealth by 117.4% during the fourth quarter. Deutsche Bank AG now owns 45,610 shares of the company’s stock worth $137,000 after buying an additional 24,635 shares in the last quarter. SG Americas Securities LLC increased its holdings in shares of NantHealth by 157.6% during the fourth quarter. SG Americas Securities LLC now owns 72,521 shares of the company’s stock worth $221,000 after buying an additional 44,372 shares in the last quarter. Millennium Management LLC acquired a new position in shares of NantHealth during the fourth quarter worth $344,000. Finally, Advisor Group Inc. acquired a new position in shares of NantHealth during the fourth quarter worth $450,000. Institutional investors and hedge funds own 5.59% of the company’s stock.
NantHealth Company Profile
NantHealth, Inc, together with its subsidiaries, operates as an evidence-based personalized healthcare company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care.
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.